Renaissance Technologies (RenTech)'s LYEL Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 130,190 shares of Lyell Immunopharma, Inc. (LYEL) worth $1.83 M, representing 0.00% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 5 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained this position in LYEL for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 76,921 shares. Largest reduction occurred in Q4 2025, reducing 24,500 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Lyell Immunopharma (LYEL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Lyell Immunopharma (LYEL) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +13,779 | Add 11.84% | 130,190 | $14.05 |
| Q1 2026 | +76,921 | Add 194.79% | 116,411 | $20.06 |
| Q4 2025 | -24,500 | Reduce 38.29% | 39,490 | $30.78 |
| Q3 2025 | -3,200 | Reduce 4.76% | 63,990 | $16.24 |
| Q2 2025 | +67,190 | New Buy | 67,190 | $8.84 |
Renaissance Technologies (RenTech)'s Lyell Immunopharma Investment FAQs
Renaissance Technologies (RenTech) first purchased Lyell Immunopharma, Inc. (LYEL) in Q2 2025, acquiring 67,190 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Lyell Immunopharma, Inc. (LYEL) for 5 quarters since Q2 2025.
Renaissance Technologies (RenTech)'s largest addition to Lyell Immunopharma, Inc. (LYEL) was in Q1 2026, adding 116,411 shares worth $2.34 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 130,190 shares of Lyell Immunopharma, Inc. (LYEL), valued at approximately $1.83 M.
As of the Q2 2026 filing, Lyell Immunopharma, Inc. (LYEL) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Lyell Immunopharma, Inc. (LYEL) was 130,190 shares, as reported at the end of Q2 2026.